New Delhi: Serum Institute of India (SII) is expected to sign a contract with the Central government to supply COVID-19 vaccine at Rs 250 per dose, Business Standard reported.
SII, which is the world’s largest vaccine producer, along with Pfizer India have applied for emergency approval of their vaccines in India.
SII CEO Adar Poonawalla had earlier revealed that the vaccine would be priced around Rs 1,000 per dose in the private market. He had also assured that the vaccine would be first supplied to Indians before exporting.
SII is producing the vaccine developed by AstraZeneca and Oxford University.
Bhubaneswar: A youth was critically injured reportedly in an armed attack by some miscreants in…
Lucknow: Imagine a man trying to kill his wife because she confided in him that she…
Kendrapada: Lightning strike during northwesterly killed two more persons including a woman in Odisha's Kendrapada district…
New Delhi: More than five weeks after being arrested by Enforcement Directorate, Arvind Kejriwal has not…
Bhubaneswar: With BJD president and Chief Minister Naveen Patnaik taking the lead in kicking off…
Bengaluru: A consumer court here has ordered Swiggy to pay Rs 3,000 as compensation and…
Bhubaneswar: What is common between Nandan Nilekani, Kota Harinarayana, Narayana Murthy, Damodar Acharya, BK Syngal,…
Bhubaneswar: The Odisha Pradesh Congress Committee (OPCC) has proposed to AICC for nominating Sofia Firdous…